Enlivex (ENLV) Assets Average (2014 - 2025)
Enlivex (ENLV) posted quarterly Assets Average of $313.9 million for Q4 2025, up 991.99% year-over-year from $28.7 million in Q4 2024, and up 1341.84% quarter-over-quarter from $21.8 million in Q3 2025.
Enlivex (ENLV) Assets Average (2014 - 2025) Analysis & Trends
Enlivex's Assets Average history runs 12 years deep, the most recent figure standing at $313.9 million for Q4 2025.
- In Q4 2025, Assets Average rose 991.99% year-over-year to $313.9 million; the TTM figure through Dec 2025 stood at $313.9 million (up 991.99% YoY), while the FY2025 annual figure was $317.2 million, up 883.4% from the prior year.
- Assets Average for Q4 2025 stood at $313.9 million, up from $21.8 million in the prior quarter.
- The five-year high for Assets Average was $313.9 million in Q4 2025, with the low at $21.8 million in Q3 2025.
- The 5-year median for Assets Average is $60.2 million (2023), against an average of $69.9 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average sank 46.83% in 2024, then surged 991.99% in 2025.
- Enlivex's Assets Average stood at $96.7 million in 2021, then dropped by 27.55% to $70.0 million in 2022, then plunged by 40.19% to $41.9 million in 2023, then sank by 31.38% to $28.7 million in 2024, then soared by 991.99% to $313.9 million in 2025.
- Business Quant data shows ENLV's Assets Average at $313.9 million in Q4 2025, $21.8 million in Q3 2025, and $23.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Enlivex | 4.52 Mn | -1.23 Mn | - | 313.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 313.86 Mn |
| Sep 30, 2025 | 21.77 Mn |
| Jun 30, 2025 | 23.32 Mn |
| Mar 31, 2025 | 25.86 Mn |
| Dec 31, 2024 | 28.74 Mn |
| Sep 30, 2024 | 30.85 Mn |
| Jun 30, 2024 | 31.47 Mn |
| Mar 31, 2024 | 33.94 Mn |
| Dec 31, 2023 | 41.88 Mn |
| Sep 30, 2023 | 49.98 Mn |
| Jun 30, 2023 | 56.53 Mn |
| Mar 31, 2023 | 63.83 Mn |
| Dec 31, 2022 | 70.03 Mn |
| Sep 30, 2022 | 74.88 Mn |
| Jun 30, 2022 | 82.98 Mn |
| Mar 31, 2022 | 91.88 Mn |
| Dec 31, 2021 | 96.66 Mn |
| Sep 30, 2021 | 96.68 Mn |
| Jun 30, 2021 | 95.57 Mn |
| Mar 31, 2021 | 68.16 Mn |